The fate of genetic data remains uncertain as 23andMe faces financial decline and potential takeover. The company's value has plummeted over 99% since its IPO in early 2021, prompting concerns about the security of customers' sensitive information. As a result, privacy advocates are urging users to take action and request data deletion before it may be sold or transferred. With no federal regulation governing genetic data, potential buyers could have different ideas about how to use this valuable trove of DNA data.

Source: https://techcrunch.com/2024/10/19/23andme-faces-an-uncertain-future-so-does-your-genetic-data/